Wayne L. Furman

8.9k total citations
197 papers, 6.1k citations indexed

About

Wayne L. Furman is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Wayne L. Furman has authored 197 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Neurology, 71 papers in Molecular Biology and 64 papers in Oncology. Recurrent topics in Wayne L. Furman's work include Neuroblastoma Research and Treatments (81 papers), Cancer therapeutics and mechanisms (50 papers) and Childhood Cancer Survivors' Quality of Life (23 papers). Wayne L. Furman is often cited by papers focused on Neuroblastoma Research and Treatments (81 papers), Cancer therapeutics and mechanisms (50 papers) and Childhood Cancer Survivors' Quality of Life (23 papers). Wayne L. Furman collaborates with scholars based in United States, Germany and Canada. Wayne L. Furman's co-authors include Victor M. Santana, Clinton F. Stewart, Sheri L. Spunt, Pamela S. Hinds, M. Beth McCarville, Laura C. Bowman, Linda L. Oakes, Peter J. Houghton, Charles B. Pratt and Catherine A. Billups and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Hepatology.

In The Last Decade

Wayne L. Furman

196 papers receiving 5.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Wayne L. Furman 1.9k 1.7k 1.6k 1.4k 1.1k 197 6.1k
CR Pinkerton 1.5k 0.8× 999 0.6× 1.3k 0.8× 939 0.7× 1.1k 1.0× 157 5.2k
Mark L. Bernstein 1.8k 0.9× 2.2k 1.3× 1.7k 1.1× 776 0.6× 667 0.6× 184 7.5k
Raymond J. Hutchinson 1.3k 0.7× 897 0.5× 1.1k 0.7× 1.5k 1.1× 1.9k 1.8× 136 5.6k
Modesto Carli 1.7k 0.9× 1.9k 1.1× 1.4k 0.9× 705 0.5× 342 0.3× 171 7.2k
Peter F. Coccia 1.5k 0.8× 1.3k 0.7× 1.1k 0.7× 1.1k 0.8× 1.7k 1.6× 108 5.7k
Teresa J. Vietti 2.2k 1.2× 1.4k 0.9× 1.3k 0.8× 777 0.6× 981 0.9× 149 8.0k
Michaël C.G. Stevens 1.1k 0.6× 638 0.4× 518 0.3× 1.3k 0.9× 841 0.8× 135 5.7k
James H. Feusner 1.3k 0.7× 2.7k 1.6× 508 0.3× 954 0.7× 1.4k 1.3× 149 6.1k
Bruce Bostrom 1.1k 0.6× 1.2k 0.7× 647 0.4× 1.9k 1.4× 2.9k 2.7× 129 6.0k
Holcombe E. Grier 2.4k 1.3× 2.0k 1.2× 1.6k 1.0× 3.0k 2.1× 2.5k 2.3× 145 11.7k

Countries citing papers authored by Wayne L. Furman

Since Specialization
Citations

This map shows the geographic impact of Wayne L. Furman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne L. Furman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne L. Furman more than expected).

Fields of papers citing papers by Wayne L. Furman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne L. Furman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne L. Furman. The network helps show where Wayne L. Furman may publish in the future.

Co-authorship network of co-authors of Wayne L. Furman

This figure shows the co-authorship network connecting the top 25 collaborators of Wayne L. Furman. A scholar is included among the top collaborators of Wayne L. Furman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne L. Furman. Wayne L. Furman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Furman, Wayne L.. (2021). Monoclonal Antibody Therapies for High Risk Neuroblastoma. Biologics. Volume 15. 205–219. 20 indexed citations
2.
Wilson, Carmen L., Tara M. Brinkman, Sujuan Huang, et al.. (2020). Clinically ascertained health outcomes, quality of life, and social attainment among adult survivors of neuroblastoma: A report from the St. Jude Lifetime Cohort. Cancer. 126(6). 1330–1338. 12 indexed citations
3.
Peitzsch, Mirko, Elizabeth R. Butch, Anastasios Mangelis, et al.. (2019). Biochemical testing for neuroblastoma using plasma free 3‐O‐methyldopa, 3‐methoxytyramine, and normetanephrine. Pediatric Blood & Cancer. 67(2). e28081–e28081. 16 indexed citations
4.
Federico, Sara M., M. Beth McCarville, Barry L. Shulkin, et al.. (2017). A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma. Clinical Cancer Research. 23(21). 6441–6449. 114 indexed citations
5.
Stricker, Thomas, Andrés Morales La Madrid, Alexandre Chlenski, et al.. (2014). Validation of a prognostic multi‐gene signature in high‐risk neuroblastoma using the high throughput digital NanoString nCounter™ system. Molecular Oncology. 8(3). 669–678. 28 indexed citations
6.
Pritchard, Michele, Elizabeth Burghen, Jami S. Gattuso, et al.. (2010). Factors That Distinguish Symptoms of Most Concern to Parents from Other Symptoms of Dying Children. Journal of Pain and Symptom Management. 39(4). 627–636. 26 indexed citations
7.
Furman, Wayne L., Fariba Navid, Najat C. Daw, et al.. (2009). Tyrosine Kinase Inhibitor Enhances the Bioavailability of Oral Irinotecan in Pediatric Patients With Refractory Solid Tumors. Journal of Clinical Oncology. 27(27). 4599–4604. 42 indexed citations
8.
Hinds, Pamela S., Linda L. Oakes, Brent Powell, et al.. (2009). “Trying to Be a Good Parent” As Defined By Interviews With Parents Who Made Phase I, Terminal Care, and Resuscitation Decisions for Their Children. Journal of Clinical Oncology. 27(35). 5979–5985. 208 indexed citations
9.
Pritchard, Michele, Deo Kumar Srivastava, James Okuma, et al.. (2009). Bereaved Parents' Perceptions About When Their Child's Cancer-Related Death Would Occur. Journal of Pain and Symptom Management. 38(4). 561–567. 12 indexed citations
10.
Sharp, Susan E., Barry L. Shulkin, Michael J. Gelfand, Shelia Salisbury, & Wayne L. Furman. (2009). 123I-MIBG Scintigraphy and 18F-FDG PET in Neuroblastoma. Journal of Nuclear Medicine. 50(8). 1237–1243. 123 indexed citations
11.
Santana, Victor M., et al.. (2008). Disease control intervals in high‐risk neuroblastoma. Cancer. 112(12). 2796–2801. 27 indexed citations
12.
Wagner, Lars M., Sylvie M. Guichard, Susana C. Raimondi, et al.. (2006). Pilot Study to Evaluate MYCN Expression as a Neuroblastoma Cell Marker to Detect Minimal Residual Disease by RT-PCR. Journal of Pediatric Hematology/Oncology. 28(10). 635–641. 1 indexed citations
13.
Sanders, Robert P. & Wayne L. Furman. (2005). Familial adenomatous polyposis in two brothers with hepatoblastoma: Implications for diagnosis and screening. Pediatric Blood & Cancer. 47(6). 851–854. 14 indexed citations
14.
McCarville, M. Beth, et al.. (2001). Sonographic appearance of appendicitis in a neutropenic pediatric patient after inversion appendectomy. Pediatric Radiology. 31(8). 578–580. 1 indexed citations
15.
Kaste, Sue C., Carlos Rodríguez‐Galindo, & Wayne L. Furman. (1999). Imaging pediatric oncologic emergencies of the abdomen.. American Journal of Roentgenology. 173(3). 729–736. 5 indexed citations
16.
Furman, Wayne L., Xiaolong Luo, Diane Fairclough, et al.. (1997). Phase I trial of subcutaneous interleukin-1α in children with malignant solid tumors. Medical and Pediatric Oncology. 28(6). 444–450. 5 indexed citations
17.
Furman, Wayne L., John H. Rodman, Margaret Tonda, et al.. (1997). Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapy. Cancer Chemotherapy and Pharmacology. 41(3). 229–236. 1 indexed citations
18.
Albuquerque, Maria Luiza C., et al.. (1995). Veno‐occlusive Disease of the Liver After Chemotherapy for Rhabdomyosarcoma: Case Report With a Review of the Literature. Medical and Pediatric Oncology. 24(5). 334–340. 21 indexed citations
19.
Rivera, Gaston K., Ching-Hon Pui, Victor M. Santana, et al.. (1993). Progress in the treatment of adolescents with acute lymphoblastic leukemia. Cancer. 71(S10). 3400–3405. 18 indexed citations
20.
Furman, Wayne L. & William M. Crist. (1991). Potential Uses of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Children. Journal of Pediatric Hematology/Oncology. 13(4). 388–399. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by CR Pinkerton Breakdown of academic impact, for papers by Mark L. Bernstein Breakdown of academic impact, for papers by Raymond J. Hutchinson Breakdown of academic impact, for papers by Modesto Carli Breakdown of academic impact, for papers by Peter F. Coccia Breakdown of academic impact, for papers by Teresa J. Vietti Breakdown of academic impact, for papers by Michaël C.G. Stevens Breakdown of academic impact, for papers by James H. Feusner Breakdown of academic impact, for papers by Bruce Bostrom Breakdown of academic impact, for papers by Holcombe E. Grier
Rankless by CCL
2026